RxDoctor Payments Data

Henry Luu

Addiction Medicine · West Chester, PANPI 1306864947

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.7% of the total across 143 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 17.8% — the pattern of someone who eats at a lot of different presentations. Among addiction medicine clinicians in PA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$4,666in general payments, 2019–2025

Across 143 payments — averaging $32.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Braeburn Inc.$829
  • Novo Nordisk$807
  • Indivior Inc.$639
  • AbbVie$636
  • Corium, LLC$588
  • AstraZeneca$361
  • plus $805 from 14 others

What the payments were for

  • Food & beverage$4,653100%
  • Education$130%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,666 in reported general payments places this provider in the 90th percentile of 82 addiction medicine providers in Pennsylvania.

See all addiction medicine providers in Pennsylvania

Most prescribed under Part D

DrugClaimsCost to plans & patients
AbrysvoRsv Vacc, Pref A And Pref B/Pf150$45,707
SublocadeBuprenorphine16$31,866
ShingrixVaricella-Zoster Ge/As01b/Pf135$28,680
ArexvyRsvpref3 Antigen/As01e/Pf49$14,555
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl99$11,780
SuboxoneBuprenorphine Hcl/Naloxone Hcl15$11,183
VyvanseLisdexamfetamine Dimesylate13$4,957
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine15$367
Sertraline Hcl13$353
Clonidine Hcl13$24

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKShingrix, Arexvy$37$43,235184 claims
Indivior Inc.Sublocade, Suboxone$639$43,04831 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 82 addiction medicine providers in Pennsylvania.

Other addiction medicine in West Chester

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →